pharmaphorum12 年
FDA approves Novartis’ Afinitor for certain breast cancers
The US FDA has approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast ...